In order to establish a causal link among the inhibition of BRAF signaling, the AMPK pathway re-activation, and the increased number of dead cells, we knocked-down AMPKα in UACC903 melanoma cells and investigated the response under low glucose conditions to the inhibition of the oncogenic BRAF signaling. Here, PRKAA2 is linked to melanoma.